A novel EGFR exon 21 indel mutation in lung adenocarcinoma and response to dacomitinib: A case report
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000030269
Abstract: Rationale: Uncommon epidermal growth factor receptor (EGFR) mutations are increasingly being identified in non-small cell lung cancer. Insertion and deletion mutations have been detected in exons 18, 19, and 20, but not in exon 21.… read more here.
Keywords: lung; patient; dacomitinib; indel mutation ... See more keywords